Top Tech to See at CES 2024: AR/VR Gets Shake Up with Multi-Depth Display Breakthrough by MIT Spinout Brelyon
Brelyon, the MIT spinout that brought to the world the first-ever headset-free virtual monitor with monocular depth, is set to break new ground again at CES with... Read more.
Jackson Healthcare Debuts on Forbes List of America’s Largest Private Companies
ATLANTA–(BUSINESS WIRE)–Jackson Healthcare®, a family of highly specialized healthcare staffing, search and technology companies, today announced that... Read more.
In Major Expansion of Private Funds Group, Houlihan Lokey Creates Best-in-Class Private Capital Advisory Platform With Acquisition of Triago
Acquisition Immediately Establishes Firm as a Comprehensive, Market-Leading Private Capital Advisor, Building Upon Firm’s Long-Term Focus on Alternative Asset... Read more.
Bragg Gaming Supplies Online Casino Game Aggregation for Superbet in Brazil
Agreement extends the supplier’s reach in soon to be regulated market TORONTO–(BUSINESS WIRE)–Bragg Gaming Group has taken its aggregation platform... Read more.
Robbins Geller Rudman & Dowd LLP and Kahn Swick & Foti, LLC Announce Proposed Settlement in the Cleco Merger Litigation
SAN DIEGO–(BUSINESS WIRE)–The following statement is being issued by Robbins Geller Rudman & Dowd LLP and Kahn Swick & Foti, LLC regarding the... Read more.
Global Menin Inhibitor Drugs Clinical Trials & Future Opportunity Insight 2023: A New Generation of Proteins that have Found Application as a Therapeutic Target in Several Prevalent Diseases – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Menin Inhibitor Drugs Clinical Trials & Future Opportunity Insight 2023” report has been added to... Read more.
DocGo Delivers Medical Services at Enchant Milwaukee’s Winter Village
NEW YORK–(BUSINESS WIRE)–DocGo Inc. (Nasdaq: DCGO), a leading provider of technology-enabled mobile health services today announced their partnership... Read more.
JCR Pharmaceuticals and Takeda Pharmaceuticals Announce Discontinuation of Gene Therapy Collaboration
HYOGO, Japan–(BUSINESS WIRE)–JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida; “JCR”) announced today that Takeda Pharmaceutical... Read more.
JCR Pharmaceuticals and Takeda Pharmaceuticals Announce Discontinuation of Gene Therapy Collaboration
HYOGO, Japan–(BUSINESS WIRE)–JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida; “JCR”) announced today that Takeda Pharmaceutical... Read more.
Arrowhead Pharmaceuticals Files for Regulatory Clearance to Initiate Phase 1/2a Study of ARO-CFB for Complement Mediated Kidney Disease
PASADENA, Calif.–(BUSINESS WIRE)–$arwr–Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has filed an application for clearance... Read more.